Franklin Genomic Advancements ETF’s (HELX) Moving Averages Convergence Divergence (MACD) indicator is 0.23, suggesting Franklin Genomic Advancements ETF is a Sell.
Franklin Genomic Advancements ETF’s (HELX) 20-Day exponential moving average is 26.61, making it a Buy.
Franklin Genomic Advancements ETF’s (HELX) 50-Day exponential moving average is 26.75, making it a Buy.